Anemia Deficiency of red cells, or hemoglobin, in the blood. Anemia is a medical condition in which the quantity of red blood cells falls below an acceptable level. Red blood cells, produced in the bone marrow, contain hemoglobin, the component of...

Anemia is a disorder in which the blood has less hemoglobin or fewer red cells than normal. With less hemoglobin, the blood carries less oxygen to the body's cells, which causes weakness, fatigue, and paleness in the anemic person. If hemoglobin levels...

Oxygen is distributed throughout the body by red blood cells, which contain an oxygen-carrying molecule called hemoglobin. Hemoglobin's ability to carry oxygen depends on iron. Red blood cells live for about 120 days. When they die, their iron is...

Anemia is a medical condition in which the red cells of the blood are reduced in number or volume or are deficient in hemoglobin, their oxygen-carrying pigment. Almost 100 different varieties of anemia are known. Iron deficiency is the most common...

Anemia (AmE) or anæmia/anaemia (BrE), from the Greek (Ἀναιμία) (an-haîma) meaning "without blood", is a deficiency of red blood cells (RBCs) and/or hemoglobin. This results in a reduced ability of blood to transfer oxygen to the tissues,...

Amgen Inc. shares have been anemic lately amid worries that sales of the company's blockbuster anti-anemia drugs might slow because of competition and safety concerns. Now, some analysts and investors say shares of the Thousand Oaks, Calif., biotechnology giant look like a bargain.The stock hasn't...

Federal health officials issued stern new warnings Friday for doctors to more carefully prescribe widely used anemia drugs that can increase the risk of death and other serious problems in patients with cancer and kidney disease.At issue are drugs sold under the brand names Procrit,...

Two months after federal regulators ordered additional warnings be added to the labels of blockbuster anemia drugs, government advisers said Thursday Amgen Inc. and Johnson & Johnson should be required to add more warnings and conduct additional safety studies.The Food and Drug Administration's outside panel...

Cancer doctors seek to loosen federal restrictions on anemia drugs that carry potentially deadly side effects, saying the tight payment guidelines for treatments made by Amgen and Johnson and Johnson are ultimately bad for patients.The American Society of Clinical Oncology says guidelines issued last month...